Analysis of The Costs Associated with Vitamin K Antagonist Treatment for Stroke Prevention in Non Valvular Atrial Fibrialltion in Mexico

The objective of this research was to quantify the collective costs of VKA treatment for patients with non-valvular atrial fibrillation (NVAF) in Mexico.

Source: Value in Health - October 29, 2016 Category: Global & Universal Authors: J Briere, K Bowrin, R Wood, T Holbrook, J Roberts Source Type: research